De novo primary liver cancer after liver transplantation: A French national study on 15 803 patients
Immunosuppression exposes recipients of liver transplant to de novo malignancies.1 However, few data are available regarding de novo primary liver cancer (PLC) and especially hepatocellular carcinoma (HCC). Indeed, interpretation of data is challenging as most PLCs after liver transplant are mainly...
Gespeichert in:
| Veröffentlicht in: | Experimental and clinical transplantation 2018-12, Vol.16 (6), p.779-780 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 780 |
|---|---|
| container_issue | 6 |
| container_start_page | 779 |
| container_title | Experimental and clinical transplantation |
| container_volume | 16 |
| creator | Altieri,Mario Allaire,Manon Dumortier,Jérôme Sérée,Olivier Coilly,Audrey Houssel Debry,Pauline Neau Cransac,Martine Pageaux,Georges Philippe |
| description | Immunosuppression exposes recipients of liver transplant to de novo malignancies.1 However, few data are available regarding de novo primary liver cancer (PLC) and especially hepatocellular carcinoma (HCC). Indeed, interpretation of data is challenging as most PLCs after liver transplant are mainly recurrence of pretransplant cancer.2 As a result, only 14 cases of de novo HCC have been reported so far in the literature; 9/12 patients had recurrence of the initial liver disease associated with cirrhosis at time of HCC diagnosis and 8 patients died. In these 14 cases, 5 patients had hepatitis B virus, 3 had hepatitis C virus (HCV), 3 had HCV + alcoholism, 2 had alcoholic liver disease, and 1 had Budd-Chiari syndrome. |
| doi_str_mv | 10.6002/ect.2018.0222 |
| format | Article |
| fullrecord | <record><control><sourceid>idealonline</sourceid><recordid>TN_cdi_idealonline_journals_IDEAL_85445</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>IDEAL_85445</sourcerecordid><originalsourceid>FETCH-idealonline_journals_IDEAL_854453</originalsourceid><addsrcrecordid>eNqNjE1rwzAQREVpIe7HMfe99WRnJUuu6C00CQn02LtZbIUqqCsjKYH8-5q2P6CXefBmGCGWEpsOUa3cUBqF0jaolLoRlZK6q61WL7eiki3qGq0xC3Gf8wmxM1qZSowbBxwvEabkvyhdIfiLSzAQDzPoWOb8VSUR5ykQFyo-8iusYZccD5_AP4IC5HIerxAZpAGLLUxz4bjkR3F3pJDd0x8fxPNu-_G2r_3oKEQOnl1_iuc0n-T-sNmu33trtDbt_5ff4UtO4g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>De novo primary liver cancer after liver transplantation: A French national study on 15 803 patients</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Altieri,Mario ; Allaire,Manon ; Dumortier,Jérôme ; Sérée,Olivier ; Coilly,Audrey ; Houssel Debry,Pauline ; Neau Cransac,Martine ; Pageaux,Georges Philippe</creator><contributor>Haberal,Mehmet</contributor><creatorcontrib>Altieri,Mario ; Allaire,Manon ; Dumortier,Jérôme ; Sérée,Olivier ; Coilly,Audrey ; Houssel Debry,Pauline ; Neau Cransac,Martine ; Pageaux,Georges Philippe ; Haberal,Mehmet</creatorcontrib><description>Immunosuppression exposes recipients of liver transplant to de novo malignancies.1 However, few data are available regarding de novo primary liver cancer (PLC) and especially hepatocellular carcinoma (HCC). Indeed, interpretation of data is challenging as most PLCs after liver transplant are mainly recurrence of pretransplant cancer.2 As a result, only 14 cases of de novo HCC have been reported so far in the literature; 9/12 patients had recurrence of the initial liver disease associated with cirrhosis at time of HCC diagnosis and 8 patients died. In these 14 cases, 5 patients had hepatitis B virus, 3 had hepatitis C virus (HCV), 3 had HCV + alcoholism, 2 had alcoholic liver disease, and 1 had Budd-Chiari syndrome.</description><identifier>ISSN: 1304-0855</identifier><identifier>EISSN: 2146-8427</identifier><identifier>DOI: 10.6002/ect.2018.0222</identifier><language>eng</language><publisher>Başkent Üniversitesi</publisher><subject>Tıp</subject><ispartof>Experimental and clinical transplantation, 2018-12, Vol.16 (6), p.779-780</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27915,27916</link.rule.ids></links><search><contributor>Haberal,Mehmet</contributor><creatorcontrib>Altieri,Mario</creatorcontrib><creatorcontrib>Allaire,Manon</creatorcontrib><creatorcontrib>Dumortier,Jérôme</creatorcontrib><creatorcontrib>Sérée,Olivier</creatorcontrib><creatorcontrib>Coilly,Audrey</creatorcontrib><creatorcontrib>Houssel Debry,Pauline</creatorcontrib><creatorcontrib>Neau Cransac,Martine</creatorcontrib><creatorcontrib>Pageaux,Georges Philippe</creatorcontrib><title>De novo primary liver cancer after liver transplantation: A French national study on 15 803 patients</title><title>Experimental and clinical transplantation</title><description>Immunosuppression exposes recipients of liver transplant to de novo malignancies.1 However, few data are available regarding de novo primary liver cancer (PLC) and especially hepatocellular carcinoma (HCC). Indeed, interpretation of data is challenging as most PLCs after liver transplant are mainly recurrence of pretransplant cancer.2 As a result, only 14 cases of de novo HCC have been reported so far in the literature; 9/12 patients had recurrence of the initial liver disease associated with cirrhosis at time of HCC diagnosis and 8 patients died. In these 14 cases, 5 patients had hepatitis B virus, 3 had hepatitis C virus (HCV), 3 had HCV + alcoholism, 2 had alcoholic liver disease, and 1 had Budd-Chiari syndrome.</description><subject>Tıp</subject><issn>1304-0855</issn><issn>2146-8427</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNqNjE1rwzAQREVpIe7HMfe99WRnJUuu6C00CQn02LtZbIUqqCsjKYH8-5q2P6CXefBmGCGWEpsOUa3cUBqF0jaolLoRlZK6q61WL7eiki3qGq0xC3Gf8wmxM1qZSowbBxwvEabkvyhdIfiLSzAQDzPoWOb8VSUR5ykQFyo-8iusYZccD5_AP4IC5HIerxAZpAGLLUxz4bjkR3F3pJDd0x8fxPNu-_G2r_3oKEQOnl1_iuc0n-T-sNmu33trtDbt_5ff4UtO4g</recordid><startdate>201812</startdate><enddate>201812</enddate><creator>Altieri,Mario</creator><creator>Allaire,Manon</creator><creator>Dumortier,Jérôme</creator><creator>Sérée,Olivier</creator><creator>Coilly,Audrey</creator><creator>Houssel Debry,Pauline</creator><creator>Neau Cransac,Martine</creator><creator>Pageaux,Georges Philippe</creator><general>Başkent Üniversitesi</general><scope>IEBAR</scope></search><sort><creationdate>201812</creationdate><title>De novo primary liver cancer after liver transplantation: A French national study on 15 803 patients</title><author>Altieri,Mario ; Allaire,Manon ; Dumortier,Jérôme ; Sérée,Olivier ; Coilly,Audrey ; Houssel Debry,Pauline ; Neau Cransac,Martine ; Pageaux,Georges Philippe</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-idealonline_journals_IDEAL_854453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Tıp</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Altieri,Mario</creatorcontrib><creatorcontrib>Allaire,Manon</creatorcontrib><creatorcontrib>Dumortier,Jérôme</creatorcontrib><creatorcontrib>Sérée,Olivier</creatorcontrib><creatorcontrib>Coilly,Audrey</creatorcontrib><creatorcontrib>Houssel Debry,Pauline</creatorcontrib><creatorcontrib>Neau Cransac,Martine</creatorcontrib><creatorcontrib>Pageaux,Georges Philippe</creatorcontrib><collection>Idealonline online kütüphane - Journals</collection><jtitle>Experimental and clinical transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Altieri,Mario</au><au>Allaire,Manon</au><au>Dumortier,Jérôme</au><au>Sérée,Olivier</au><au>Coilly,Audrey</au><au>Houssel Debry,Pauline</au><au>Neau Cransac,Martine</au><au>Pageaux,Georges Philippe</au><au>Haberal,Mehmet</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>De novo primary liver cancer after liver transplantation: A French national study on 15 803 patients</atitle><jtitle>Experimental and clinical transplantation</jtitle><date>2018-12</date><risdate>2018</risdate><volume>16</volume><issue>6</issue><spage>779</spage><epage>780</epage><pages>779-780</pages><issn>1304-0855</issn><eissn>2146-8427</eissn><abstract>Immunosuppression exposes recipients of liver transplant to de novo malignancies.1 However, few data are available regarding de novo primary liver cancer (PLC) and especially hepatocellular carcinoma (HCC). Indeed, interpretation of data is challenging as most PLCs after liver transplant are mainly recurrence of pretransplant cancer.2 As a result, only 14 cases of de novo HCC have been reported so far in the literature; 9/12 patients had recurrence of the initial liver disease associated with cirrhosis at time of HCC diagnosis and 8 patients died. In these 14 cases, 5 patients had hepatitis B virus, 3 had hepatitis C virus (HCV), 3 had HCV + alcoholism, 2 had alcoholic liver disease, and 1 had Budd-Chiari syndrome.</abstract><pub>Başkent Üniversitesi</pub><doi>10.6002/ect.2018.0222</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1304-0855 |
| ispartof | Experimental and clinical transplantation, 2018-12, Vol.16 (6), p.779-780 |
| issn | 1304-0855 2146-8427 |
| language | eng |
| recordid | cdi_idealonline_journals_IDEAL_85445 |
| source | EZB-FREE-00999 freely available EZB journals |
| subjects | Tıp |
| title | De novo primary liver cancer after liver transplantation: A French national study on 15 803 patients |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T00%3A16%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-idealonline&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=De%20novo%20primary%20liver%20cancer%20after%20liver%20transplantation:%20A%20French%20national%20study%20on%2015%20803%20patients&rft.jtitle=Experimental%20and%20clinical%20transplantation&rft.au=Altieri,Mario&rft.date=2018-12&rft.volume=16&rft.issue=6&rft.spage=779&rft.epage=780&rft.pages=779-780&rft.issn=1304-0855&rft.eissn=2146-8427&rft_id=info:doi/10.6002/ect.2018.0222&rft_dat=%3Cidealonline%3EIDEAL_85445%3C/idealonline%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |